CLARK TOBLER: Open Payments
NPI 1619406287 · REDDING, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$461 in 16 payments from 12 companies in 2025. Trend: 2023 $120 · 2024 $180 · 2025 $461
Food & beverage: $461
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $137 |
| Novo Nordisk Inc | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| ABBVIE INC. | 2 | $41 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $17 |
Products named: VENASEAL, Rybelsus, REXULTI, LINZESS, JOURNAVX, CAPLYTA, XIFAXAN, FARXIGA.
Industry payments across CA — which companies pay providers there.
